American Journal of Neuroradiology 25:1144-1146, August 2004
© 2004 American Society of Neuroradiology
INTERVENTIONAL
Intralesional Bleomycin Injections for the Palliation of Epistaxis in Hereditary Hemorrhagic Telangiectasia
a Unitas Interventional Unit, Centurion, South Africa
b Olivedale Clinic, Randburg, South Africa
Address reprint requests to Ian C. Duncan, Unitas Interventional Unit, PO Box 14031, Lyttelton, 0140, South Africa
Summary: Epistaxis is a common complication in patients with hereditary hemorrhagic telangiectasia. Its treatment is generally aimed at controlling the frequency and severity of nasal hemorrhage and involves surgery, transcatheter embolization, topical treatment, or a combination. Despite this multitude of treatment methods, the long-term prognosis for many patients remains poor. We describe a patient in whom direct intralesional injections of bleomycin successfully palliated severe recurrent epistaxis for almost 2 years without the need for adjuvant therapy.
This article has been cited by other articles:
![]() |
P.W.A. Willems, R.I. Farb, and R. Agid Endovascular Treatment of Epistaxis AJNR Am. J. Neuroradiol., October 1, 2009; 30(9): 1637 - 1645. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.F. Layton, D.F. Kallmes, L.A. Gray, and H.J. Cloft Endovascular Treatment of Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia AJNR Am. J. Neuroradiol., May 1, 2007; 28(5): 885 - 888. [Abstract] [Full Text] [PDF] |
||||
